1. Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?

   • Gilles Edan
   • Emmanuelle Le Page

   Current Opinion Open access 09 May 2013 Pages: 403 - 409

2. Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention

   • Mathieu Nollet
   • Samuel Leman

   Leading Article 09 May 2013 Pages: 411 - 422

3. The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain

   • Meng He
   • Chao Deng
   • Xu-Feng Huang

   Review Article 03 May 2013 Pages: 423 - 434

   

4. The Long-Term Safety of Antiepileptic Drugs

   • Athanasios Gaitatzis
   • Josemir W. Sander

   Review Article 15 May 2013 Pages: 435 - 455

5. Publication Bias, with a Focus on Psychiatry: Causes and Solutions

   • Erick H. Turner

   Review Article 22 May 2013 Pages: 457 - 468

6. The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

   • George T. Grossberg
   • Facundo Manes
   • Stephen M. Graham

   Original Research Article Open access 04 June 2013 Pages: 469 - 478

   

7. Loxapine Inhalation Powder: A Review of its Use in the Acute Treatment of Agitation in Patients with Bipolar Disorder or Schizophrenia

   • Gillian M. Keating

   Adis Drug Evaluation 06 June 2013 Pages: 479 - 489

   

8. Erratum to: The Role of Antipsychotics in the Management of Fibromyalgia

   • Elena P. Calandre
   • Fernando Rico-Villademoros

   Erratum 17 May 2013 Pages: 491 - 491